Our Institute brings together scientists and clinicians from all UCSF campuses to address the most critical and intractable questions related to Aging.

San Francisco, CA
We bring together UCSF scientists and clinicians to uncover mechanisms behind aging, develop novel diagnostic/therapeutic tools, and establish best practices for providing equitable care to older adults in our communities. geroscience.ucsf.edu/
5
27
Bacteria have immune systems that kill infected cells to stop phage spread. In Molecular Cell, BARI’s Seth Shipman and colleagues show a non-canonical retron that only makes DNA when phage arrives, then uses that DNA to unlock translation of a toxin. sciencedirect.com/science/ar…
1
117
Exciting opportunity at UCSF! The Department of Cell and Tissue Biology is recruiting a tenure-track Assistant or Associate Professor studying the cell biology of disease, with applications on the cell biology of aging especially encouraged!
1
5
13
2,549
BARI’s Guo Huang & colleagues identify Coq10a, a muscle-enriched mitochondrial protein as a regulator of postnatal heart growth. In PNAS, loss of Coq10a drives heart enlargement via altered coenzyme Q distribution and PPAR signaling, without hurting normal energy production.
1
2
6
256
New tools for phage therapy screening: BARI’s Seth Shipman reports Detectrons, which converts a detected RNA sequence into a durable DNA barcode. In Nature Biotechnology, they show multiplexed, live-cell detection of which phages infect bacteria. pubmed.ncbi.nlm.nih.gov/4283…
1
119
BARI’s Aric Prather reports a small randomized trial of lemborexant for daytime sleep in night-shift workers. The drug didn’t beat placebo overall, but participants on the 10mg dose showed a signal worth testing in larger studies. link.springer.com/article/10…
1
118
BARI’s Dengke Ma reviews strategies to take on APOE4 in Alzheimer’s. The focus is restoring healthy cholesterol handling in the brain, with approaches that range from small molecules to antibodies and systemic lipid drugs. febs.onlinelibrary.wiley.com…
85
When TBK1 doesn’t work well enough, cells struggle to clear waste and control inflammation. In this new review, BARI’s Daniel Mordes explains how this dual hit contributes to ALS and related dementias, and what it means for future therapies. frontiersin.org/journals/neu…
2
5
216
Aging tissues get stiffer, and more fragile. In the Journal of Cell Science, BARI’s Hanna Martens & colleagues review how failed mechanotransduction, from matrix to nucleus, drives senescence & inflammation, and how resetting that niche might rejuvenate tissue.
1
1
3
278
One binding site often means choosing potency or selectivity. BARI’s Kevan Shokat & team link two ligands on the same kinase and apply the idea to ABL1 leukemia. In Nature: their lead compound PonatiLink-2 stays potent against resistance and is better tolerated in mice.
1
136
BARI’s Margaret Wallhagen & colleagues invite nurses to help shape geroscience. Nursing’s prevention-focused, person-centered perspective is a natural fit, and the field will be stronger with that voice in education, research, practice, and policy. nursingoutlook.org/article/S…
91
In Geroscience, BARI’s Scott Bauer reports that walking energies, but not peak fitness, track with urinary symptoms in adults 70+. Higher walking energy cost was linked in incontinence in men. link.springer.com/article/10…
1
102
Blood-brain barrier cell types are undercounted in many single-cell studies. BARI’s Andrew Yang shares a Nature Protocols method to isolate cerebral vessels and recover high-quality nuclei for downstream multi-omics. nature.com/articles/s41596-0…
1
1
2
212
This week is Postdoc Appreciation Week and we’re grateful for the BARI postdocs who keep our science moving! You bring the experiments, the ideas, the late nights, and the questions that push aging biology forward. Thank you for being such a vital part of this community!
1
3
167
CDK4/6 inhibitors transformed some cancer treatment, then resistance emerged. In a Nature Chemical Biology Perspective, BARI’s Kevan Shokat maps emerging CDK2 targeting strategies to stay ahead of resistance. nature.com/articles/s41589-0…
113
Respiration isn’t just “use oxygen.” In Trends in Biochemical Sciences, BARI’s Isha Jain surveys the many terminal electron acceptors eukaryotes still use, and why those backup routes shape health in low-oxygen settings. cell.com/action/showPdf?pii=…
3
236
BARI’s Martin Kampmann and team ran a genome-wide CRISPRi screen in human microglia and found 772 genes that control the interferon-responsive state linked to aging and neurodegeneration. New regulators plus a resource for turning this program up or down. bit.ly/4reK3az
1
1
2
259